Chris Cestaro

VP Marketing & Business Development
Zephyr Health

Chris Cestaro is the Vice President of Marketing and Business Development at Zephyr Health, the Insights-as-a-Service leader harnessing the power of global healthcare data to address critical business and patient needs. He leads the go-to-market strategies for commercializing Zephyr Health’s innovative, enterprise solutions.

With over 15 years experience in Marketing, Sales, and Business Development, Chris is a thought leader on lifecycle, go-to-market strategy, vertical solutions, and sales and partner enablement for Healthcare and Life Sciences markets worldwide.

Prior to joining Zephyr Health Chris spent 4 years with SalesForce.com leading the Healthcare and Life Sciences division and prior to that was Vice President and General Manager of Product Lifecycle for Ventana Medical Device Company, a division of Roche Group.

Chris holds an MBA from Goizueta Business at Emory University and a Certificate in Biotech for Executives from Northwestern University.

Check out the incredible speaker line-up to see who will be joining Chris.

Download The Latest Agenda

Marketing & Sales Integration Focus Day For Pharma Manufacturers Only

Monday, March 9th, 2015

13:45 Innovation Exchange: Rotation #1

These Innovation Exchange roundtable discussions are at the heart of the Integration Focus Day. Sit down with 10 – 15 other pharma executives, share solutions to common challenges, and ask the burning question you need an answer to. Because no other vendors attend these roundtables, you’ll be pleased by how candid the conversations are. Plus you get to choose your own adventure: pick the three topics that will pack the biggest punch for your 2015/2016 promotional strategies.

Choose one of six topics:

#1 Multichannel Patient Engagement
Peter Lammers, VP, Integrated Multichannel Engagement, Quintiles

#2 Are We Thinking Broadly Enough About Our Go-to-Market Model In Pharma?
Bill Coyle, Principal, ZS Associates

#3 A Prescription For Pharma Marketing And Sales Alignment
Marilyn Cox, Marketing Principal, Oracle Marketing Cloud

#4 Telemedicine And Remote Monitoring: Establishing Their Role In Pharma Marketing
Valencia Courts, VP Clinical Operations, PharmacistPartners

#5 Avoiding Paralysis By Analysis – What To Do With Big Data
Chris Cestaro, VP Marketing & Business Development, Zephyr Health

Would your firm benefit from collaborative discussions with marketing and sales executives? Contact sponsorship director Alicia Upchurch at alicia.upchurch@wbresearch.com or 646-200-7452 to get involved.

Stakeholder Engagement Strategies In The New Healthcare Era

Thursday, April 9th, 2015

09:10 PANEL: Launch Readiness And Planning Best Practices

There are 400 drug launches predicted over the next 3 years globally. Brand managers need to gear up their marketing strategy and data of potential prescribers and patients, and need to ensure their sales teams are trained effectively in the new drug’s science to communicate it to payers and physicians. This also requires a shifting of resources in the sales team to ensure proper coverage (should the drug be part of a portfolio, or should reps focus solely on the new drug?) Learn from some of big pharma's best launch leaders:

Planning appropriate launch timelines
Building a comprehensive launch training plan
Determining what kind of commercial efforts will yield the best results